Holista Colltech Ltd
Research Holista Colltech Ltd (HCT) on Bullrun: market cap AUD 16.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHCT
- ExchangeAU
- CountryAustralia
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyAUD
- Market capAUD 16.92M
- Financial periodFY2025
- RevenueAUD 5.76M
- Revenue growth3.0%
- Net income-AUD 948.92K
- Free cash flow-AUD 1.55M
- Gross margin51.3%
Valuation Snapshot
latest market cap is AUD 16.92M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 5.76M | -AUD 948.92K | -AUD 1.55M | 51.3% | 0 | AUD 2.16M | AUD 1.59M | AUD 1.12M |
| FY2024 | AUD 5.60M | -AUD 84.21K | -AUD 1.02M | 50.0% | 0 | AUD 217.16K | AUD 1.77M | -AUD 1.73M |
| FY2023 | AUD 5.95M | -AUD 2.26M | -AUD 456.37K | 53.2% | -0.01 | AUD 59.77K | AUD 1.57M | AUD 570.26K |
| FY2022 | AUD 8.24M | -AUD 1.45M | -AUD 1.26M | 51.5% | -0.01 | AUD 117.53K | AUD 1.22M | AUD 2.83M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 16.92M | n/a | n/a | n/a |
About Holista Colltech Ltd
Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Holista Colltech Ltd's market cap?
Holista Colltech Ltd's market capitalization is AUD 16.92M.
What does Holista Colltech Ltd do?
Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.